Recently Added Contracts

Natural Health Trends Corp – NOTICE OF RATIFICATION OF POTENTIALLY DEFECTIVE CORPORATE ACTS (October 11th, 2019)

Notice is hereby given pursuant to Section 204 of the Delaware General Corporation Law ( “Section 204 of the DGCL”), that on October 10, 2019, the Board of Directors (“Board”) of Natural Health Trends Corp., a Delaware corporation (the “Company”), adopted resolutions approving the ratification of potentially defective corporate acts, as described below, pursuant to Section 204 of the DGCL.

Raytheon Co/ – UTC Media Inquiries Raytheon Media Inquiries (October 11th, 2019)

WALTHAM, Mass. and FARMINGTON, Conn., October 11, 2019 – Raytheon Company (NYSE: RTN) and United Technologies Corp. (NYSE: UTX) announced that, at their respective special meetings of shareowners held today, Raytheon and United Technologies shareowners voted overwhelmingly to approve all of the proposals necessary to complete the merger of equals transaction combining United Technologies’ aerospace businesses, comprised of Collins Aerospace and Pratt & Whitney, with Raytheon. The merger would create Raytheon Technologies Corporation, a premier systems provider with advanced technologies to address rapidly growing segments within aerospace and defense.

Usa Technologies Inc – USA Technologies Reports Fiscal Year 2019 and 2018 Results (October 11th, 2019)

MALVERN, Pa. – October 9, 2019 – USA Technologies, Inc. (OTC:USAT) (“USAT” or the “Company”), a cashless payments and software services company that provides end-to-end technology solutions for the self-service retail market, today reported results for the fiscal years ended June 30, 2019 and June 30, 2018. Additionally, based upon the adjustments identified by an internal investigation that the Company announced in September 2018, as well as further adjustments subsequently identified by management during the audit process, the Company has restated results for the fiscal year ended June 30, 2017, restated selected financial data for the fiscal years ended June 30, 2015 and 2016, and restated results for the quarterly periods ended September 30, 2016 and 2017, December 31, 2016 and 2017, and March 31, 2017 and 2018. The Company has also reported results for the fiscal quarters ended September 30, 2018, December 31, 2018, and March 31, 2019. As previously disclosed, on a net basis, the

Galileo Acquisition Corp. – Galileo Acquisition Corp. PO Box 309, Ugland House Grand Cayman KY1-1104 Cayman Islands (October 11th, 2019)

We have acted as counsel as to Cayman Islands law to Galileo Acquisition Corp. (the "Company") in connection with the Company's registration statement on Form S-1, including all amendments or supplements thereto, filed with the United States Securities and Exchange Commission (the "Commission") under the United States Securities Act of 1933, as amended (the "Act") (including its exhibits, the "Registration Statement") for the purposes of, registering with the Commission under the Act, the offering and sale of:

Galera Therapeutics, Inc. – GALERA THERAPEUTICS, INC. EQUITY INCENTIVE PLAN (October 11th, 2019)
Pharma-Bio Serv, Inc. – EMPLOYMENT AGREEMENT AMENDMENT (October 11th, 2019)

EMPLOYMENT AGREEMENT AMENDMENT (this "Amendment"), effective as of October 7, 2019, by and among Pharma-Bio Serv, Inc. with its principal office at 6 Road 696, Dorado, Puerto Rico 00646 (the “Company”), and Pedro J. Lasanta (“Executive”) (both hereinafter “the Parties”).

Centogene B.V. – FORM OF LONG-TERM INCENTIVE PLAN CENTOGENE N.V. (October 11th, 2019)
Streamline Health Solutions Inc. – SECURITIES PURCHASE AGREEMENT (October 11th, 2019)

This Securities Purchase Agreement (this “Agreement”) is dated as of October 10, 2019, between Streamline Health Solutions, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

BRP Group, Inc. – THIRD AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT of BALDWIN RISK PARTNERS, LLC Dated as of [●], 2019 (October 11th, 2019)

THIRD AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT (this “Agreement”) OF BALDWIN RISK PARTNERS, LLC, a Delaware limited liability company (the “Company”), dated as of [•], by and among the Company, BRP Group, Inc., a Delaware corporation (“Pubco”), and the other Persons listed on the signature pages hereto.

Drone Aviation Holding Corp. – DRONE AVIATION HOLDING CORP. and CLEARTRUST, LLC, as Warrant Agent Warrant Agency Agreement Dated as of October __, 2019 WARRANT AGENCY AGREEMENT (October 11th, 2019)

WARRANT AGENCY AGREEMENT, dated as of October __, 2019 (“Agreement”), between Drone Aviation Holding Corp., a corporation organized under the laws of the State of Nevada (the “Company”), and ClearTrust, LLC (the “Warrant Agent”).

Idt Corp – IDT CORPORATION 2015 STOCK OPTION AND INCENTIVE PLAN Effective January 1, 2015 to September 16, 2024 (Amended and Restated on September 12, 2019) (October 11th, 2019)
Galileo Acquisition Corp. – INVESTMENT MANAGEMENT TRUST AGREEMENT (October 11th, 2019)

This Agreement is made as of ____, 2019 by and between Galileo Acquisition Corp. (the “Company”) and Continental Stock Transfer & Trust Company, as trustee (“Trustee”).

Galileo Acquisition Corp. – Galileo Acquisition Corp. (October 11th, 2019)

This letter is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and between Galileo Acquisition Corp., a Cayman Islands exempted company (the “Company”), and EarlyBirdCapital, Inc., as representative (the “Representative”) of the several Underwriters named in Schedule I thereto (the “Underwriters”), relating to an underwritten initial public offering (the “IPO”) of the Company’s units (the “Units”), each comprised of one ordinary share of the Company, par value $0.0001 per share (the “Ordinary Shares”), and one redeemable warrant (the “Warrants”), each redeemable Warrant entitling the holder thereof to purchase one Ordinary Share at a price of $11.50 per share. Certain capitalized terms used herein are defined in paragraph 14 hereof.

Synthesis Energy Systems Inc – REGISTRATION RIGHTS AGREEMENT (October 11th, 2019)

This Registration Rights Agreement (this “Agreement”) is made and entered into as of October __, 2019, between Synthesis Energy Systems, Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).

NEUROONE MEDICAL TECHNOLOGIES Corp – LEASE AGREEMENT (October 11th, 2019)
Osprey Technology Acquisition Corp. – PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT (October 11th, 2019)

THIS PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT, effective as of , 2019 (as it may from time to time be amended, this “Agreement”), is entered into by and between Osprey Technology Acquisition Corp., a Delaware corporation (the “Company”), and Osprey Sponsor II, LLC, a Delaware limited liability company (the “Purchaser”).

Yield10 Bioscience, Inc. – COMMON STOCK PURCHASE WARRANT (October 11th, 2019)

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, CEDE & CO. or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Authorized Share Increase Date (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the five and one-half year anniversary of the date hereof (the “Termination Date”) but not thereafter, to subscribe for and purchase from Yield10 Bioscience, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee (“DTC”) shall initially be the s

Eos Inc. – FORM OF REVISED HOUSING RENTAL CONTRACT Rental Payment and Collection Table (October 11th, 2019)
Synthesis Energy Systems Inc – MANAGEMENT CONSULTING AGREEMENT (October 11th, 2019)

THIS MANAGEMENT CONSULTING AGREEMENT is made this 10th day of October, 2019 (the “Effective Date”), by and between Market Development Consulting Group, Inc. d/b/a MDC Group (“Consultant”), a Wisconsin corporation with mailing address 7845 N. Links Circle, Fox Point, Wisconsin 53217, and Synthesis Energy Systems, Inc., (“Company”), a Delaware corporation with principal executive offices located at One Riverway, Suite 1700, Houston, Texas, 77056.

Alfacourse Inc. – STOCK PURCHASE AGREEMENT (October 11th, 2019)

THIS STOCK PURCHASE AGREEMENT (this “Agreement”) is made as of October 8, 2019 by and among Heritage Equity Fund LP (“Purchaser”), Alfacourse Inc., a Nevada corporation (the “Company”), and Oleg Jitov (the “Selling Party”, and the “Executive”). The Purchaser, the Company and the Selling Party are sometimes collectively referred to herein as the “Parties” and individually referred to herein as a “Party.”

New Age Beverages Corp – SECOND AMENDMENT And Waiver TO LOAN AND SECURITY AGREEMENT (October 11th, 2019)

This SECOND AMENDMENT AND WAIVER TO LOAN AND SECURITY AGREEMENT (this “Second Amendment”) is made and entered into as of October 9, 2019, by and between EAST WEST BANK, a Delaware corporation (“Bank”), and NEW AGE BEVERAGES CORPORATION, a Washington corporation (“Borrower”).

FTE Networks, Inc. – STANDSTILL AGREEMENT (October 11th, 2019)

In connection with the transactions contemplated by that certain Proposal For Surrender Of Collateral And Strict Foreclosure (the “Proposal”), dated as of October 10, 2019, to FTE Networks, Inc. (“FTE”), and certain other parties named therein, from Lateral Juscom Feeder LLC, in order to induce FTE to enter into the Proposal and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, you hereby agree as set forth herein.

Wells Fargo & Company/Mn – [Face of Note] (October 11th, 2019)

Unless this certificate is presented by an authorized representative of The Depository Trust Company, a New York corporation (“DTC”), to the Company or its agent for registration of transfer, exchange or payment, and any certificate issued is registered in the name of Cede & Co. or in such other name as requested by an authorized representative of DTC (and any payment is made to Cede & Co. or such other entity as is requested by an authorized representative of DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL inasmuch as the registered owner hereof, Cede & Co., has an interest herein.

Galera Therapeutics, Inc. – Page ARTICLE 1 Offices 1 1.1 Principal Office 1 1.2 Additional Offices 1 ARTICLE 2 Meeting of Stockholders 1 2.1 Place of Meeting 1 2.2 Action Without Meeting by Written Consent 1 2.3 Annual Meeting 1 2.4 Special Meetings 1 2.5 Notice of Meetings 2 2.6 Business Matter of a Special Meeting 2 2.7 List of Stockholders 2 2.8 Organization and Conduct of Business 2 2.9 Quorum and Adjournments 3 2.10 Voting Rights 3 2.11 Majority Vote 3 2.12 Record Date for Stockholder Notice and Voting 3 2.13 Proxies 3 2.14 Inspectors of Election 4 ARTICLE 3 Directors 4 3.1 Number: Qualifications 4 3.2 Resignation a (October 11th, 2019)
Adynxx, Inc. – COMMON STOCK PURCHASE WARRANT ADYNXX, INC. (October 11th, 2019)

THIS WARRANT TO PURCHASE COMMON STOCK (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [ISSUE DATE] (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on , 20241 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Adynxx, Inc., a Delaware corporation (the “Company”), up to shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).